Comparison of intranasal and nebulized dexmedetomidine for premedication in pediatric patients: A non-inferiority randomized controlled trial

BACKGROUND AND AIMS: Dexmedetomidine is a highly selective α-2 adrenoreceptor agonist and has been found to be an effective premedication agent when administered via the intranasal route. We aimed to compare the efficacy of dexmedetomidine premedication administered via intranasal route and through...

Descripción completa

Detalles Bibliográficos
Autores principales: Verma, Shilpi, Bhatia, Pradeep Kumar, Sharma, Vandana, Mohammed, Sadik, Saran, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912882/
https://www.ncbi.nlm.nih.gov/pubmed/36778820
http://dx.doi.org/10.4103/joacp.JOACP_6_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912882/
https://www.ncbi.nlm.nih.gov/pubmed/36778820
http://dx.doi.org/10.4103/joacp.JOACP_6_21

Ejemplares similares